Literature DB >> 2996503

Calpain inhibition by peptide epoxides.

C Parkes, A A Kembhavi, A J Barrett.   

Abstract

A Ca2+-activated cysteine proteinase (calpain II) was purified from chicken gizzard smooth muscle by use of isoelectric precipitation, (NH4)2SO4 fractionation, chromatography on DEAE-Sepharose CL-6B, Reactive-Red 120-agarose and Mono Q. The apparent second-order rate constants for the inactivation of calpain by a series of structural analogues of L-3-carboxy-trans-2, 3-epoxypropionyl-leucylamido-(4-guanidino)butane (E-64) were determined. The fastest rate of inactivation was observed with L-3-carboxy-trans-2, 3-epoxypropionyl-leucylamido-(4-benzyloxy-carbonylamino)buta ne. It was possible to determine the active-site molarity of solutions of calpain by titration with E-64. When incubated with Ca2+, calpain underwent several steps of intermolecular limited proteolysis, via multiple pathways, followed by a slower loss of enzymic activity. The proteolytic steps preceding the loss of activity did not affect the rates of reaction of calpain with E-64 analogues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996503      PMCID: PMC1152644          DOI: 10.1042/bj2300509

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Evidence for two structurally different forms of skeletal muscle Ca2+-activated protease.

Authors:  M J Wheelock
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

2.  Calcium-activated proteases in mammalian tissues.

Authors:  L Waxman
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Amino acid sequence around the active site cysteine residue of calcium-activated neutral protease (CANP).

Authors:  K Suzuki; H Hayashi; T Hayashi; K Iwai
Journal:  FEBS Lett       Date:  1983-02-07       Impact factor: 4.124

4.  Comparison of low- and high-calcium-requiring forms of the calcium-activated protease with their autocatalytic breakdown products.

Authors:  W R Dayton
Journal:  Biochim Biophys Acta       Date:  1982-12-20

5.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

6.  Rabbit skeletal muscle calcium-dependent protease requiring millimolar CA2+. Purification, subunit structure, and Ca2+-dependent autoproteolysis.

Authors:  R L Mellgren; A Repetti; T C Muck; J Easly
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

7.  Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease.

Authors:  A Kishimoto; N Kajikawa; M Shiota; Y Nishizuka
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

8.  Limited autolysis reduces the Ca2+ requirement of a smooth muscle Ca2+-activated protease.

Authors:  D R Hathaway; D K Werth; J R Haeberle
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

9.  Characterization of a brain calcium-activated protease that degrades neurofilament proteins.

Authors:  U J Zimmerman; W W Schlaepfer
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

10.  Identification of Ca2+-activated neutral protease in the peripheral nerve and its effects on neurofilament degeneration.

Authors:  K Kamakura; S Ishiura; H Sugita; Y Toyokura
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

View more
  31 in total

1.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective.

Authors:  K K Wang; R Nath; A Posner; K J Raser; M Buroker-Kilgore; I Hajimohammadreza; W Probert A; F W Marcoux; Q Ye; E Takano; M Hatanaka; M Maki; H Caner; J L Collins; A Fergus; K S Lee; E A Lunney; S J Hays; P Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.

Authors:  Isaac T Schiefer; Subhasish Tapadar; Vladislav Litosh; Marton Siklos; Rob Scism; Gihani T Wijewickrama; Esala P Chandrasena; Vaishali Sinha; Ehsan Tavassoli; Michael Brunsteiner; Mauro Fa'; Ottavio Arancio; Pavel Petukhov; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

5.  Investigation of the structural basis of the interaction of calpain II with phospholipid and with carbohydrate.

Authors:  C Crawford; N R Brown; A C Willis
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

6.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

7.  Enhanced tumor retention of NTSR1-targeted agents by employing a hydrophilic cysteine cathepsin inhibitor.

Authors:  Wei Fan; Wenting Zhang; Sameer Alshehri; Trey R Neeley; Jered C Garrison
Journal:  Eur J Med Chem       Date:  2019-05-25       Impact factor: 6.514

8.  The effects of autolysis on the structure of chicken calpain II.

Authors:  C Crawford; A C Willis; J Gagnon
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

9.  Inhibitory effects of spermine and spermidine on muscle calpain II.

Authors:  P Johnson; J L Hammer
Journal:  Experientia       Date:  1990-03-15

10.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.